Paper Review Records
All Paper Review Records
15 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
104
days
Spatial remodeling of bone marrow architecture defines tissue-state signatures of disease activity and therapeutic response in myelodysplastic neoplasms
Authors
Ryan Nachman; Aleksandra Kopacz; Caitlin Unkenholz; Jian Chai; Arvin Ruiz; Itzel Valencia; Jeanne Jiang; Fabio Socciarelli; Jiwoon Park; Christopher E. Mason; Ling Zhang; David Sallman; Gail J. Roboz; Pinkal Desai; Justin Kaner; Joshua Fein; Monica Guzman; Neal Lindeman; Amy Chadburn; Madhu Ouseph; Paul Simonson; Julia Geyer; Giorgio Inghirami; Shahin Rafii; David Redmond; Sanjay S. PatelShow moreShow less
Affiliations
1. Division of Regenerative Medicine, Department of Medicine, Hartman Institute for Therapeutic Organ Regeneration, Ansary Stem Cell Institute, Weill Cornell Medicine, New York, USA; 2. Multiparametric In Situ Imaging (MISI) Laboratory, Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, USA; 3. Division of Hematopathology, Department of Pathology and Laboratory Medicine, Weill Cornell Medicine/NewYork-Presbyterian Hospital, New York, USA; 4. Immunopathology Laboratory, Weill Cornell Medical College/NewYork-Presbyterian Hospital, New York, USA; 5. Department of Physiology and Biophysics, Weill Cornell Medicine, New York, USA; 6. The Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, USA; 7. WorldQuant Initiative for Quantitative Prediction, Weill Cornell Medicine, New York, USA; 8. The HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine, Weill Cornell Medicine, New York, USA; 9. Department of Hematopathology and Laboratory Medicine, Moffitt Cancer Center, Tampa, USA; 10. Department of Malignant Hematology, Moffitt Cancer Center, Tampa, USA; 11. Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine/NewYork-Presbyterian Hospital, New York, USA; 12. Division of Molecular Genetic Pathology, Department of Pathology and Laboratory Medicine, Weill Cornell Medicine/NewYork-Presbyterian Hospital, New York, USAShow moreShow less
111
days
Lineage-restricted dependency on an oncofetal SNHG29 -IGF2BP1 RNA axis in acute megakaryoblastic leukemia
Authors
Robert Winkler; Bruno Griesler; Wolfgang Sippl; Reinier A. Boon; Stefanie Dimmeler; Ilka Wittig; Marie-Laure Yaspo; Stefan Hüttelmaier; Raj Bhayadia; Dirk Heckl; Jan-Henning KlusmannShow moreShow less
Affiliations
1. Department of Pediatrics, Goethe University Frankfurt, Frankfurt am Main, Germany; 2. Frankfurt Cancer Institute, Frankfurt/Main, Germany; 3. German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Partner site, Frankfurt/Mainz, Germany; 4. Institute of Molecular Medicine, Martin Luther University Halle-Wittenberg, Halle, Germany; 5. University Clinic and Outpatient Clinic for Internal Medicine IV, University Medicine Halle (Saale), Halle (Saale), Germany; 6. Institute for Cardiovascular Regeneration, Centre for Molecular Medicine, Goethe University, Frankfurt Am Main, Germany; 7. German Centre for Cardiovascular Research, Partner Site Frankfurt Rhein/Main, Frankfurt, Germany; 8. Department of Physiology, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands; 9. Amsterdam Cardiovascular Sciences, Amsterdam, the Netherlands; 10. Max Planck Institute for Molecular Genetics, Berlin, Germany; 11. School of Health Sciences and Technology, UPES, Dehradun, India; 12. Institute for Experimental Pediatric Hematology and Oncology, Goethe University Frankfurt, Frankfurt am Main, GermanyShow moreShow less
174
days
FATP2-mediated lipid metabolism enhances chimeric antigen receptor T-cell therapy resistance in B-cell acute lymphoblastic leukemia
Authors
Clarissa Garcia; Kaylyn U. Lyons; Julian Grandvallet Contreras; Tian Liu; Alexis J. Donnelly; Amanda J. Novak; Amy Argabright; Colin Anderson; Abby Grier; Sabrina Smith; Joshua Michlin; Jesutomisin Olusoji; Railey G. Mikeska; Xin Zhou; Huimin Geng; Jeremy T. Rahkola; Hiten N. Patel; Jeffrey G. Jacot; Markus Müschen; Angelo D’Alessandro; John E. Dick; Ilaria Iacobucci; Charles G. Mullighan; Julie A. Reisz; Tzu Phang; M. Eric Kohler; Matthew T. WitkowskiShow moreShow less
Affiliations
1. Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, USA; 2. Department of Biochemistry and Molecular Genetics, University of Colorado Anschutz Medical Campus, Aurora, USA; 3. Department of Molecular Genetics, University of Toronto, Princess Margaret Hospital, University Health Network, Princess Margaret Cancer Research Tower, Toronto, Canada; 4. Department of Pathology, St Jude Children’s Research Hospital, Memphis, USA; 5. Department of Laboratory Medicine, University of California San Francisco, San Francisco, USA; 6. Rocky Mountain Regional Veteran Affairs Medical Center, Aurora, USA; 7. Department of Bioengineering, University of Colorado Anschutz Medical Campus, Aurora, USA; 8. Division of Pediatrics, Children’s Hospital Colorado, Aurora, USA; 9. Center of Molecular and Cellular Oncology, Yale Cancer Center, Yale University, New Haven, USA; 10. Division of Blood and Marrow Transplant & Cellular Therapeutics, Center for Cancer and Blood Disorders, Children’s Hospital Colorado, Aurora, USA; 11. Division of Hematology, University of Colorado Anschutz Medical Campus, Aurora, USAShow moreShow less
216
days
Selective sensitivity of Ph-like B-cell acute lymphoblastic leukemia to BRG1 inhibition identifies a therapeutic vulnerability
Authors
V. S. S. Abhinav Ayyadevara; Ria Perencsik; Shreya Patil; Shikha Gaur; Ashley Paik; Monika Toma; Gerald Wertheim; Huimin Geng; Tomasz Skorski; Srividya Swaminathan; Christian HurtzShow moreShow less
Affiliations
1. Department of Basic Science, Division of Cancer Sciences, Loma Linda University School of Medicine, Loma Linda, USA; 2. University of British Columbia, Vancouver, Canada; 3. Southern Adventist University, Collegedale, USA; 4. Fels Cancer Institute for Personalized Medicine, Lewis Katz School of Medicine, Temple University Philadelphia, Philadelphia, USA; 5. Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, USA; 6. Department of Laboratory Medicine, University of California, San Francisco, USA; 7. Department of Cancer and Cellular Biology, Lewis Katz School of Medicine, Temple University Philadelphia, Philadelphia, USA; 8. Nuclear Dynamics and Cancer Program, Fox Chase Cancer Center, Philadelphia, USA; 9. Department of Systems Biology, City of Hope Beckman Research Institute, Duarte, USA; 10. Department of Pediatrics, City of Hope Beckman Research Institute, Duarte, USAShow moreShow less
41
days
Prof. Richard T Silver—Pioneer of MPN 18 January, 1929–17 April, 2026
Authors
Rüdiger HehlmannShow moreShow less
Affiliations
1. Medizinische Fakultät Mannheim, Universität Heidelberg, ELN Foundation Weinheim, Mannheim, GermanyShow moreShow less
77
days
From data to evidence: why administrative databases alone cannot measure real-world effectiveness in rare diseases – the case of chronic myeloid leukaemia
Authors
Sara Mucherino; Enrica Menditto; Valentina OrlandoShow moreShow less
Affiliations
1. Department of Pharmacy, University of Naples Federico II, Naples, Italy; 2. CIRFF, Centre of Pharmacoeconomics and Drug Utilization Research, University of Naples Federico II, Naples, ItalyShow moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review62 days
Median65 days